Associated Papers
Clinical Implication of CDH1 Mutations in Genetic Testing for Diffuse Gastric Cancer Patients.
Corso G et al.
Oncology, 2024
E-Cadherin (CDH1 Gene) Germline Mutations in Gastric Cancer: Evolutions and Innovations.
Corso G et al.
Cancers, 2020
E-cadherin germline mutations in Māori population.
De Scalzi AM et al.
Future Oncology (london, England), 2019
Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
Guilford P et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2010
Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene.
More H et al.
Human Mutation, 2007
A model to infer the pathogenic significance of CDH1 germline missense variants.
Suriano G et al.
Journal of Molecular Medicine (berlin, Germany), 2006
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
Brooks-Wilson AR et al.
Journal of Medical Genetics, 2004
Genetic screening for familial gastric cancer.
Oliveira C et al.
Hereditary Cancer in Clinical Practice, 2004
Genetic screening for hereditary diffuse gastric cancer.
Oliveira C et al.
Expert Review of Molecular Diagnostics, 2003
Preventive gastrectomy in patients with gastric cancer risk due to genetic alterations of the E-cadherin gene defect.
Schwarz A
Langenbeck's Archives of Surgery, 2003
Familial gastric cancer: overview and guidelines for management.
Caldas C et al.
Journal of Medical Genetics, 1999
Select a paper to view details